Discovery of SIRT3 inhibitors using SAMDI mass spectrometry

Journal of Biomolecular Screening

Volumn 20, Issue 7, 2015, Pages 842-848

  Patel, Kaushal ^a   Sherrill, John ^a   Mrksich, Milan ^b   Scholle, Michael D ^a,b  

^a SAMDI Tech Inc ^*  (United States)

^b Northwestern University   (United States)

Author keywords

deacetylase; label free; peptide array; self assembled monolayers

Indexed keywords

ANTINEOPLASTIC AGENT; LYSINE; SDX 437; SIRTUIN 1; SIRTUIN 3; SIRTUIN 3 INHIBITOR; SURAMIN; UNCLASSIFIED DRUG; HISTONE DEACETYLASE INHIBITOR;

ACETYLATION; ANALYTIC METHOD; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DEACETYLATION; DRUG SELECTIVITY; HIGH THROUGHPUT SCREENING; IC50; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN MICROARRAY; SELF ASSEMBLED MONOLAYER DESORPTION IONIZATION MASS SPECTROMETRY; ANTAGONISTS AND INHIBITORS; DRUG DEVELOPMENT; DRUG EFFECTS; ENZYME ACTIVATION; HUMAN; PROCEDURES;

ACETYLATION; DRUG DISCOVERY; ENZYME ACTIVATION; HIGH-THROUGHPUT SCREENING ASSAYS; HISTONE DEACETYLASE INHIBITORS; HUMANS; MASS SPECTROMETRY; SIRTUIN 3;

EID: 84937874482     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057115588512     Document Type: Article

References (15)

1. Zhang K., Tian S., Fan E., Protein Lysine Acetylation Analysis: Current MS-Based Proteomic Technologies. The Analyst. 2013, 138, 1628-1636.
2. Weir H. J., Lane J. D., Balthasar N., SIRT3: A Central Regulator of Mitochondrial Adaptation in Health and Disease. Genes Cancer. 2013, 4, 118-124.
3. Darkin-Rattray S. J., Gurnett A. M., Myers R. W.,. Apicidin: A Novel Antiprotozoal Agent That Inhibits Parasite Histone Deacetylase. Proc. Natl. Acad. Sci. USA. 1996, 93, 13143-13147.
4. Kolle D., Brosch G., Lechner T.,. Biochemical Methods for Analysis of Histone Deacetylases. Methods. 1998, 15, 323-331.
5. Riester D., Hildmann C., Schwienhorst A.,. Histone Deacetylase Inhibitor Assay Based on Fluorescence Resonance Energy Transfer. Anal. Biochem. 2007, 362, 136-141.
6. Pacholec M., Bleasdale J. E., Chrunyk B.,. SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1. J. Biol. Chem. 2010, 285, 8340-8351.
7. Adam G. C., Meng J., Rizzo J. M.,. Use of High-Throughput Mass Spectrometry to Reduce False Positives in Protease uHTS Screens. J. Biomol. Screen. 2015, 20, 212-222.
8. Min D. H., Yeo W. S., Mrksich M., A Method for Connecting Solution-Phase Enzyme Activity Assays with Immobilized Format Analysis by Mass Spectrometry. Anal. Chem. 2004, 76, 3923-3929.
9. Li J., Thiara P. S., Mrksich M., Rapid Evaluation and Screening of Interfacial Reactions on Self-Assembled Monolayers. Langmuir Surf. Coll. 2007, 23, 11826-11835.
10. Kim J., Mrksich M., Profiling the Selectivity of DNA Ligases in an Array Format with Mass Spectrometry. Nucl. Acids Res. 2010, 38, e2.
11. Zhang J. H., Chung T. D., Oldenburg K. R., A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999, 4, 67-73.
12. Smith B. C., Settles B., Hallows W. C.,. SIRT3 Substrate Specificity Determined By Peptide Arrays and Machine Learning. ACS Chem. Biol. 2011, 6, 146-157.
13. Wigle T. J., Swinger K. K., Campbell J. E.,. A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening. J. Biomol. Screen. 2015, 10.1177/1087057115575689.
14. Schuetz A., Min J., Antoshenko T.,. Structural Basis of Inhibition of the Human NAD+-Dependent Deacetylase SIRT5 by Suramin. Structure. 2007, 15, 377-389.
15. Madiraju C., Welsh K., Cuddy M. P.,. TR-FRET-Based High-Throughput Screening Assay for Identification of UBC13 Inhibitors. J. Biomol. Screen. 2012, 17, 163-176.